These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 11998799

  • 1. PRESERVE trial surprises with unexpected results on LV hypertrophy reduction with calcium channel blockers.
    Cardiovasc J S Afr; 2002; 13(1):37-8. PubMed ID: 11998799
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of blood pressure reduction with trandolapril and enalapril on left ventricular hypertrophy and exercise tolerance.
    Leonetti G, Fogari R, Mazzola C, Pasotti C, Ponti GB, Marelli C, Zanchetti A.
    J Hypertens Suppl; 1993 Dec; 11(5):S356-7. PubMed ID: 8158420
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of changes in blood pressure and left ventricular mass induced by antihypertensive treatment on ventricular arrhythmias in essential hypertension.
    Muiesan ML, Zulli R, Rizzoni D, Calebich S, Malerba M, Porteri E, Agabiti-Rosei E.
    J Hypertens Suppl; 1993 Dec; 11(5):S104-5. PubMed ID: 8158296
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril.
    González-Juanatey JR, García-Acuña JM, Pose A, Varela A, Calvo C, Cabezas-Cerrato J, de la Peña MG.
    Am J Cardiol; 1998 Jan 15; 81(2):170-4. PubMed ID: 9591900
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relation to changes in neurohumoral factors.
    Ueno H, Takata M, Tomita S, Oh-hashi S, Yasumoto K, Inoue H.
    J Cardiovasc Pharmacol; 1997 Nov 15; 30(5):643-8. PubMed ID: 9388047
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H, Takata Y, Yamashina A.
    Nihon Rinsho; 2004 Mar 15; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract] [Full Text] [Related]

  • 20. [Calcium antagonist against hypertension. Arteriosclerosis controlled].
    MMW Fortschr Med; 2002 Oct 17; 144(42):63. PubMed ID: 12534002
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.